STEVENAGE BIOSCIENCE CATALYST - Profile & Financials

Accounts Submitted 19 Dec 2024

Confirmation Statement Submitted 24 Mar 2025

Net assets £4.99M £613.89K 2024 year on year

Total assets £24.14M £1.27M 2024 year on year

Total Liabilities £19.15M £1.88M 2024 year on year

Charges 4

4 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage Hertfordshire SG1 2FX

Telephone

0143 890 6906

adam.rudman@lifearc.org

Website

stevenagecatalyst.com

Credit Report

Discover STEVENAGE BIOSCIENCE CATALYST's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£2.11M

Decreased by £1.91M (-48%)

Net Assets

£4.99M

Increased by £613.89k (+14%)

Total Liabilities

£19.15M

Decreased by £1.88M (-9%)

Turnover

£5.46M

Increased by £364.35k (+7%)

Employees

Increased by 2 (+13%)

Debt Ratio

79%

Decreased by 4 (-5%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

6 active 11 resigned

Show resigned officers

						Status
Ann Jacqueline Hunter	Director	British	England	69	1 Sept 2020	Active
Graham Paul Rivers	Director	British	United Kingdom	54	20 Jul 2023	Active
Jonathan Alexander Green	Director	British	United Kingdom	68	30 Aug 2019	Active
Lynn Drummond	Director	British	England	66	1 May 2023	Active
Sally Ann Forsyth	Director	British	England	63	5 Mar 2018	Active
Uday Prabhakar Phadke	Director	British	United Kingdom	73	3 Apr 2023	Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (2)

2 Active

The Wellcome Trust Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Voting Rights 25 To 50 Percent

Glaxosmithkline Research & Development Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Voting Rights 25 To 50 Percent

See All Controllers

Group Structure

GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

THE WELLCOME TRUST LIMITED united kingdom

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

STEVENAGE BIOSCIENCE CATALYST Current Company

Charges

4 satisfied

Documents

Company Filings

Date	Category	Description	Document
24 Mar 2025	Confirmation Statement	Confirmation statement made on 2025-03-19 with no updates	View(3 pages)
19 Dec 2024	Accounts	Annual accounts made up to 2024-03-31	View(23 pages)
20 Mar 2024	Confirmation Statement	Confirmation statement made on 2024-03-19 with no updates	View(3 pages)
30 Aug 2023	Officers	Appointment of Graham Paul Rivers as director on 2023-07-20	View(2 pages)
29 Aug 2023	Officers	Termination of James Russell Wheatcroft as director on 2023-07-20	View(1 page)